AxoGen, Inc. (AXGN) vs Fortrea Holdings Inc. (FTRE)
A side-by-side comparison of AxoGen, Inc. and Fortrea Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXGN
AxoGen, Inc.
$36.42HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
FTRE
Fortrea Holdings Inc.
$21.29HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — AXGN vs FTRE
growth of $100 · dividends reinvested · last 3yAXGN +288.5% (+57.2%/yr)FTRE -34.0% (-12.9%/yr)AXGN compounded faster over this window
Log scale — wide-divergence pair
AXGN FTRE
AXGN vs FTRE: by the numbers
- •FTRE is the larger company ($2.02B vs $1.96B market cap).
- •Both run net losses; FTRE's is the smaller (-3.18% vs -13.36% net margin).
- •AXGN grew revenue faster over the past five years (13.99% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | AXGN | FTRE |
|---|---|---|
| Forward P/E | 82.29 | 25.31 |
| P/S ratio | 7.79 | 0.76 |
| P/B ratio | 7.64 | 3.86 |
| EV / EBITDA | N/A | 33.29 |
| FCF yield | 0.13% | 7.44% |
Profitability
| Metric | AXGN | FTRE |
|---|---|---|
| Gross margin | 74.56% | 17.11% |
| Operating margin | -5.12% | 0.41% |
| Net margin | -13.36% | -3.18% |
| ROE | -13.09% | -16.25% |
| ROIC | -4.68% | 0.62% |
Growth (annualized)
| Metric | AXGN | FTRE |
|---|---|---|
| Revenue CAGR (5Y) | 13.99% | 1.09% |
| FCF CAGR (5Y) | N/A | -12.98% |
| Total return CAGR (5Y) | 19.40% | N/A |
Frequently asked
- Which has grown faster, AXGN or FTRE?
- Over the past five years, AXGN grew revenue faster — AXGN at a 13.99% CAGR versus FTRE at 1.09%.
Go deeper
Dig into the metrics
AxoGen ROEFortrea ROEAxoGen operating marginFortrea operating marginAxoGen revenue growthFortrea revenue growthAxoGen free cash flowFortrea free cash flow
AxoGen & Fortrea appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.